PMC:7545298 / 2971-3638
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T3 | 182-192 | Body_part | denotes | Antibodies | http://purl.org/sig/ont/fma/fma62871 |
| T4 | 254-258 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T18 | 78-87 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T19 | 93-101 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T20 | 368-376 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T21 | 476-485 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T20 | 230-231 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T21 | 252-258 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T-cell |
| T22 | 386-387 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T23 | 403-408 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T24 | 462-469 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
| T25 | 509-514 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T26 | 531-532 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 40 | 93-103 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 41 | 338-344 | Species | denotes | people | Tax:9606 |
| 42 | 368-378 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 43 | 487-514 | Species | denotes | respiratory syncytial virus | Tax:12814 |
| 44 | 450-461 | Species | denotes | respiratory | Tax:12814 |
| 45 | 78-87 | Disease | denotes | infection | MESH:D007239 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T23 | 0-181 | Sentence | denotes | An important caveat is that the duration of protective immunity after natural infection with SARS-CoV-2 is not currently known, and is one of the most urgent questions for research. |
| T24 | 182-320 | Sentence | denotes | Antibodies have been shown to last for at least a few months [3], and T-cell responses are likely to persist for several years more [4,5]. |
| T25 | 321-522 | Sentence | denotes | Nevertheless, if people can be reinfected with SARS-CoV-2 within a few years, the virus could become endemic like other seasonal respiratory viruses (e.g. influenza, respiratory syncytial virus, etc.). |
| T26 | 523-667 | Sentence | denotes | In such a case, herd immunity might only be achievable through vaccination, which might have to be repeated in order to sustain immunity levels. |